LEADER 01540nam  2200433   450 
001 9910716927803321
005 20211119085810.0
035   $a(CKB)5470000002526920
035   $a(OCoLC)1285683267
035   $a(EXLCZ)995470000002526920
100   $a20211119d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aVaccine development $ecapabilities and challenges for addressing infectious diseases : report to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2021.
215   $a1 online resource (iii, 75 pages) $ccolor illustrations
300   $a"November 2011."
300   $a"GAO-22-104371."
320   $aIncludes bibliographical references.
517   $aVaccine development 
606   $aVaccines$xDevelopment$xTechnological innovations$zUnited States
606   $aVaccination$zUnited States
606   $aCOVID-19 (Disease)$xVaccination$zUnited States
606   $aPublic health administration$zUnited States
606   $aCOVID-19 Pandemic, 2020-$zUnited States
615  0$aVaccines$xDevelopment$xTechnological innovations
615  0$aVaccination
615  0$aCOVID-19 (Disease)$xVaccination
615  0$aPublic health administration
615  0$aCOVID-19 Pandemic, 2020-
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910716927803321
996   $aVaccine Development$92902994
997   $aUNINA